78 related articles for article (PubMed ID: 26521331)
1. NYU Bluestone Center Receives Award to Study Oral Cancer Pain.
N Y State Dent J; 2015; 81(5):65. PubMed ID: 26521331
[No Abstract] [Full Text] [Related]
2. Remote nerve injection of mu opioid receptor adeno-associated viral vector increases antinociception of intrathecal morphine.
Gu Y; Xu Y; Li GW; Huang LY
J Pain; 2005 Jul; 6(7):447-54. PubMed ID: 15993823
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for oral cancer: recent progress in research.
Shillitoe EJ
Oral Oncol; 1998 May; 34(3):157-60. PubMed ID: 9692048
[No Abstract] [Full Text] [Related]
4. Transient overexpression of kappa and mu opioid receptors using recombinant adenovirus vectors.
Zhen Z; Bradel-Tretheway BG; Dewhurst S; Bidlack JM
J Neurosci Methods; 2004 Jul; 136(2):133-9. PubMed ID: 15183265
[TBL] [Abstract][Full Text] [Related]
5. Efficient nonviral gene therapy with FasL and Del1 fragments in mice.
Kitano H; Mamiya A; Kokubun S; Hidai C
J Gene Med; 2012 Nov; 14(11):642-50. PubMed ID: 23136083
[TBL] [Abstract][Full Text] [Related]
6. [p53 gene therapy for oral cancer].
Liu SX; Hu M
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Sep; 47(9):569-72. PubMed ID: 23141735
[No Abstract] [Full Text] [Related]
7. Gene therapy--its potential in the management of oral cancer.
Shillitoe EJ; Lapeyre JN; Adler-Storthz K
Eur J Cancer B Oral Oncol; 1994 May; 30B(3):143-54. PubMed ID: 7920160
[TBL] [Abstract][Full Text] [Related]
8. The application of genomic and molecular data in the treatment of chronic cancer pain.
Turabi A; Plunkett AR
J Surg Oncol; 2012 Apr; 105(5):494-501. PubMed ID: 22441902
[TBL] [Abstract][Full Text] [Related]
9. Winners and losers and oncolytic adenoviruses: who should be down in the mouth?
Harrington KJ
Gene Ther; 2010 Dec; 17(12):1421-2. PubMed ID: 20668484
[No Abstract] [Full Text] [Related]
10. Oral cancer: comprehending the condition, causes, controversies, control and consequences. 13. Pain.
Diz Dios P; Scully C
Dent Update; 2012; 39(1):65-7. PubMed ID: 22720384
[No Abstract] [Full Text] [Related]
11. Gene therapy in the management of oral cancer: review of the literature.
Ayllón Barbellido S; Campo Trapero J; Cano Sánchez J; Perea García MA; Escudero Castaño N; Bascones Martínez A
Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E15-21. PubMed ID: 18167474
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for oral cancer: efficient delivery of a 'suicide gene' to murine oral cancer cells in physiological milieu.
Young M; Overlid N; Konopka K; Düzgünes N
J Calif Dent Assoc; 2005 Dec; 33(12):967-71. PubMed ID: 16454240
[TBL] [Abstract][Full Text] [Related]
13. Polysaccharide gene transfection agents.
Khan W; Hosseinkhani H; Ickowicz D; Hong PD; Yu DS; Domb AJ
Acta Biomater; 2012 Dec; 8(12):4224-32. PubMed ID: 23022542
[TBL] [Abstract][Full Text] [Related]
14. Polyethylenimine-mediated PUMA gene delivery to orthotopic oral cancer: suppression of tumor growth through apoptosis induction in situ and prolonged survival.
Yeh CC; Hsieh HL; Lee J; Jan YH; Lai TC; Hong CY; Hsiao M; Kuo MY
Head Neck; 2011 Jun; 33(6):878-85. PubMed ID: 20737492
[TBL] [Abstract][Full Text] [Related]
15. Nonviral gene delivery: thinking of silica.
Luo D; Saltzman WM
Gene Ther; 2006 Apr; 13(7):585-6. PubMed ID: 17526071
[No Abstract] [Full Text] [Related]
16. Avidin-biotin interaction mediated peptide assemblies as efficient gene delivery vectors for cancer therapy.
Qu W; Chen WH; Kuang Y; Zeng X; Cheng SX; Zhou X; Zhuo RX; Zhang XZ
Mol Pharm; 2013 Jan; 10(1):261-9. PubMed ID: 23146022
[TBL] [Abstract][Full Text] [Related]
17. High antitumor activity using intratumoral injection of plasmid DNA with mutant-type p27Kip1 gene following in vivo electroporation.
Harada K; Supriatno ; Kawaguchi S; Onoue T; Kawashima Y; Yoshida H; Sato M
Oncol Rep; 2005 Feb; 13(2):201-6. PubMed ID: 15645112
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
[TBL] [Abstract][Full Text] [Related]
19. The virtues and vices of harnessing HSV vectors for CNS autoimmunity modulation.
Hukkanen V; Nygårdas M
Immunotherapy; 2013 Sep; 5(9):911-3. PubMed ID: 23998724
[No Abstract] [Full Text] [Related]
20. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
